<DOC>
	<DOCNO>NCT01125410</DOCNO>
	<brief_summary>The purpose clinical study evaluate whether vaginal tablet contain 10 mg dequalinium chloride ( Fluomizin ) comparable clinical efficacy safety clindamycin vaginal cream ( 2 % ) patient suffer bacterial vaginosis .</brief_summary>
	<brief_title>Comparative Study Efficacy 10 mg Dequalinium Chloride ( Fluomizin ) Local Treatment Bacterial Vaginosis</brief_title>
	<detailed_description>An international , multi-center , single-blind , randomize , active-controlled study two parallel group patient bacterial vaginosis . Eligible patient randomize receive Fluomizin vaginal tablet 6 day Clindamycin vaginal cream ( 2 % ) 7 day . Control examinations perform 3 14 day 2 6 week end therapy .</detailed_description>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Dequalinium</mesh_term>
	<criteria>Diagnosis bacterial vaginosis Women age 1855 year Pregnancy lactation Uterine bleeding ( include menstruation include cervical contact bleed sample ) vaginal bleed unknown origin Acute infection upper genital tract Clinical Symptoms vulvovaginal Candidiasis Use antiinfectives ( local systemic ) previous 14 day and/or study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Fluomizin</keyword>
	<keyword>Dequalinium chloride</keyword>
	<keyword>Bacterial vaginosis</keyword>
	<keyword>vaginal therapy</keyword>
</DOC>